Validation of a Novel Fluorescent Lateral Flow Assay for Rapid Qualitative and Quantitative Assessment of Total Anti-SARS-CoV-2 S-RBD Binding Antibody Units (BAU) from Plasma or Fingerstick Whole-Blood of COVID-19 Vaccinees.

Autor: Younes N; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar., Al-Sadeq DW; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; College of Medicine, QU Health, Qatar University, Doha 2713, Qatar., Shurrab FM; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar., Zedan HT; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar., Abou-Saleh H; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Biological Science Program, Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, Doha, 2713, Qatar., Abo-Halawa BY; Biological Science Program, Department of Biological and Environmental Sciences, College of Arts and Sciences, Qatar University, Doha, 2713, Qatar., AlHamaydeh FM; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar., Elsharafi AE; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar., Daas HI; College of Dental Medicine, QU Health, Qatar University, Doha 2713, Qatar., Thomas S; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar., Aboalmaaly S; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar., Al Farsi A; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar., Al-Buainain R; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar., Ataelmannan S; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar., Paul J; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar., Al Saadi AS; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar., Yassine HM; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar., Majdalawieh AF; Department of Biology, Chemistry and Environmental Sciences, College of Arts and Sciences, American University of Sharjah, Sharjah 26666, United Arab Emirates., Ismail A; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha 42, Qatar., Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha 24144, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha 24144, Qatar.; Department of Healthcare Policy and Research, Weill Cornell Medicine, Cornell University, New York, NY 10065, USA., Nasrallah GK; Biomedical Research Center, Qatar University, Doha 2713, Qatar.; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha 2713, Qatar.

Publikováno v: Vaccines [Vaccines (Basel)] 2022 Aug 15; Vol. 10 (8). Date of Electronic Publication: 2022 Aug 15.